A new class of drugs, Lu-PSMA-617, track down i prostate cancers resistant achieving good success and extending the life of patients.
This was declared by an international team of researchers including Professor Johann de Bono, Professor of Experimental Cancer Medicine at the Institute of Cancer Research, London, and Medical Oncologist Advisor at the Royal Marsden NHS Foundation Trust, and Professor Ken Herrmann, Director of the Nuclear Medicine Clinic at the University Hospital from Essen, Germany.
Read Also
- Mental health: At the Maison Perchée, young people suffering from bipolarity and schizophrenia help each other Nov 19, 2022
- Covid Italy, “90% of patients in resuscitation not vaccinated” Aug 10, 2021
- Covid-19, statins for cholesterol reduce the risk of death by half Jul 20, 2021
- Called a fruit that you cannot eat for Breakfast Jul 2, 2020
- Bodybuilding helped Dwayne Johnson through his depression Nov 18, 2022
- An Israeli study says the South African alternative can ‘penetrate’ Pfizer vaccine protection, but the vaccine is very effective Apr 19, 2021
- Mosquitoes Is it a hard mosquito summer now? Two hundred years ago, an Italian explorer wandered through the forests of Laplan Jul 4, 2021